1. Home
  2. OCGN vs BNED Comparison

OCGN vs BNED Comparison

Compare OCGN & BNED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • BNED
  • Stock Information
  • Founded
  • OCGN 2013
  • BNED 1965
  • Country
  • OCGN United States
  • BNED United States
  • Employees
  • OCGN N/A
  • BNED N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • BNED Other Specialty Stores
  • Sector
  • OCGN Health Care
  • BNED Consumer Discretionary
  • Exchange
  • OCGN Nasdaq
  • BNED Nasdaq
  • Market Cap
  • OCGN 252.4M
  • BNED 266.6M
  • IPO Year
  • OCGN N/A
  • BNED N/A
  • Fundamental
  • Price
  • OCGN $0.91
  • BNED $10.35
  • Analyst Decision
  • OCGN Strong Buy
  • BNED Hold
  • Analyst Count
  • OCGN 3
  • BNED 2
  • Target Price
  • OCGN $5.67
  • BNED $125.00
  • AVG Volume (30 Days)
  • OCGN 4.3M
  • BNED 329.4K
  • Earning Date
  • OCGN 11-08-2024
  • BNED 01-04-2025
  • Dividend Yield
  • OCGN N/A
  • BNED N/A
  • EPS Growth
  • OCGN N/A
  • BNED N/A
  • EPS
  • OCGN N/A
  • BNED N/A
  • Revenue
  • OCGN $4,700,000.00
  • BNED $1,566,405,000.00
  • Revenue This Year
  • OCGN N/A
  • BNED $5.54
  • Revenue Next Year
  • OCGN N/A
  • BNED N/A
  • P/E Ratio
  • OCGN N/A
  • BNED N/A
  • Revenue Growth
  • OCGN N/A
  • BNED 0.88
  • 52 Week Low
  • OCGN $0.36
  • BNED $6.05
  • 52 Week High
  • OCGN $2.11
  • BNED $226.00
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 44.59
  • BNED 52.87
  • Support Level
  • OCGN $0.85
  • BNED $9.41
  • Resistance Level
  • OCGN $0.94
  • BNED $10.36
  • Average True Range (ATR)
  • OCGN 0.08
  • BNED 0.96
  • MACD
  • OCGN -0.01
  • BNED -0.00
  • Stochastic Oscillator
  • OCGN 19.64
  • BNED 27.64

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is an operator of bookstores in college and university campuses across the United States. The company is also engaged in providing digital education services. It operates in three reportable segments that include Retail offers existing and prospective clients the flexibility of physical, virtual, or custom store solutions, and wholesale is comprised of the wholesale and virtual retail fulfillment, and support operations of the MBS subsidiary, also Corporate Services represent unallocated shared-service costs which include corporate level expenses and other governance functions, including executive functions, such as accounting, legal, treasury, information technology, and human resources. It earns majority of the revenue from Retail segment.

Share on Social Networks: